Document Detail

Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.
MedLine Citation:
PMID:  22336865     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is a general agreement that oxytocin given either through the intramuscular or intravenous route is effective in reducing postpartum blood loss. However, it is unclear whether the subtle differences between the mode of action of these routes have any effect on maternal and infant outcomes.
OBJECTIVES: To determine the comparative effectiveness and safety of oxytocin administered intramuscularly or intravenously for prophylactic management of the third stage of labour after vaginal birth.
SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 December 2011).
SELECTION CRITERIA: Randomised trials comparing intramuscular with intravenous oxytocin for prophylactic management of the third stage of labour after vaginal birth. We excluded quasi-randomised trials.
DATA COLLECTION AND ANALYSIS: Two review authors planned to independently assess trials for inclusion, assess risk of bias and extract data.
MAIN RESULTS: The search strategies identified no trials for consideration but we identified one ongoing study.
AUTHORS' CONCLUSIONS: There is no evidence from randomised trials to evaluate the comparative benefits and risks of intramuscular and intravenous oxytocin when given to prevent excessive blood loss after vaginal birth. Randomised trials with adequate design and sample sizes are needed to assess whether the route of prophylactic oxytocin after vaginal birth affects maternal or infant outcomes. Such trials should be large enough to detect clinically important differences in major side effects reported in observational studies and also to consider the acceptability of the intervention to mothers and providers as important outcomes.
Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos
Related Documents :
22368655 - Palliative balloon dilation of native coarctation of the aorta in a preterm infant.
6859005 - Questionable traumatic deaths and their assessment.
20084555 - Congenital mesenteric abnormality causing death in an infant with a concurrent diaphrag...
12065365 - Incidence of ards in an adult population of northeast ohio.
3956315 - Prematurity stereotyping: effects on mother-infant interaction.
1611935 - The influence of perinatal risk status on contingency learning in six- to thirteen-mont...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review     Date:  2012-02-15
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  2     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2012  
Date Detail:
Created Date:  2012-02-16     Completed Date:  2012-05-23     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD009332     Citation Subset:  IM    
Maternal and Fetal Health Research Unit, Department of Obstetrics and Gynaecology, Obafemi Awolowo College of Health Sciences,Olabisi Onabanjo University, Sagamu, Nigeria. tixon
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Injections, Intramuscular
Injections, Intravenous
Labor Stage, Third*
Oxytocics / administration & dosage*
Oxytocin / administration & dosage*
Postpartum Hemorrhage / prevention & control*
Reg. No./Substance:
0/Oxytocics; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lacosamide for neuropathic pain and fibromyalgia in adults.
Next Document:  Advance misoprostol distribution for preventing and treating postpartum haemorrhage.